Neoadjuvant immunotherapy offers a survival benefit in specific subtypes of patients but seems to offer no benefit in the ...

Among four approaches, perioperative chemotherapy and trimodality therapy were associated with better survival outcomes in ...

Statin use during concurrent chemoradiotherapy (CCRT) for advanced nasopharyngeal cancer (NPC) is associated with a 52% ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Regularly Drinking Alcohol After 60 Linked to Early Death People over age 60 who drink alcohol regularly are at an increased risk of early death, particularly from cancer or issues related to the ...

Oct. 24, 2024 – The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer. Marketed under the brand name Vyloy, the drug is to ...

But when your breast cancer is described as HER2-positive, it means the cancer cells have more HER2 protein than usual. Since this protein can make cancer cells grow more quickly, it’s natural ...

These cancer atlases reveal how different tumor cells -- and the cells of a tumor's surrounding environment -- are organized, in 3D, and how that ... Computational Tool Developed to Predict ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

If you or a loved one has lung cancer, you may be interested in learning more about medicines used to treat it. One option is an immunotherapy medicine called Imfinzi (durvalumab). Immunotherapy ...